Egg Donation

NaProTECHNOLOGY^TM is a women’s health science that monitors and maintains a woman’s reproductive and gynecologic health. It is the fruit of 30 years of research on women’s fertility, offering medical and surgical treatments that cooperate with the reproductive system, rather than suppressing or altering it. Most of the research supporting NaPro TECHNOLOGY has been conducted by Dr. Thomas W. Hilgers at the Pope Paul VI Institute for the Study of Human Reproduction in Omaha, Nebraska.

This is the first women’s health science—which is fertility care-based (rather than control-based)—that actually integrates family planning with monitoring of reproductive health and gynecologic health maintenance, by using a woman’s biomarkers (the various hormonal events that occur over the course of the menstrual cycle). Monitoring the biomarkers provides valid information about the hormonal and physiologic events (such as ovulation) of the menstrual cycle that can be interpreted by the woman user, and by physicians trained in this system.

Abnormal functions of the fertility system can be identified by monitoring the biomarkers, and treatment plans cooperate with the menstrual and fertility cycles to correct the abnormality, maintain the ecology of the woman’s body, and sustain her procreative potential. NaProTECHNOLOGY is designed to promote gynecologic and reproductive health throughout a woman’s life.

Dr. Mark Stegman, a Senior Fellow of the Westchester Institute, is a board-certified obstetrician-gynecologist and a certified FertilityCare Medical Consultant. He practices at the Center for Women’s Health in Camp Hill, PA, specializing in the use of NaProTECHNOLOGY TM for the evaluation and treatment of women’s’ health problems, especially infertility.

Send Response